Study Stops Early On Cholesterol Drug
nbc10.com     22-May-2008            

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. The halted study, called ACHIEVE, used... [read full story]                    


View all news articles about*:
Ambulatory America Care Cholesterol Drugs Health Jersey KGaA Medical Medicines Merck North Patients Pharmaceuticals Remedies Research States Trenton United
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Intercell's partner Merck initiates Phase II study of bacterial vaccine

pharmiweb.co.uk     yesterday          

Datamonitor Pharmaceutical and HealthWire - Aug. 28, 2008 Austria-based biotechnology company Intercell has announced that its collaborator Merck & Co has initiated a Phase II clinical trial of V710, an investigational...                    

comments

                   

Cervical cancer advances give hope to poor

mirror.co.uk     yesterday   5 related          

By Michael Kahn, LONDON (Reuters) 28/08/2008 New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers...                    

comments

Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before No..

euroinvestor.co.uk     4 hrs ago   2 related          

Pfizer Inc said today that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company’s favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor. The...                    

comments

Pharma is warned to harness internet

pharmiweb.co.uk     1 hr ago          

Gemma O'Reilly 29-Aug-08 Healthcare PROs have been advised to reconsider their approach to patient communications following new research that shows the expanding reach of the internet. Ogilvy Healthworld questioned 1,800...                    

comments